Particle.news

Download on the App Store

Salk Institute Identifies Affective Pain Circuit, Eyes Migraine Drugs for Therapy

They aim to test CGRP antagonists in translational studies to silence the thalamic pathway that drives emotional responses to pain without dulling sensation.

Image

Overview

  • Researchers mapped a new spinothalamic pathway in mice where CGRP-expressing neurons in the parvocellular subparafascicular thalamus relay pain signals directly to the amygdala, challenging the view of separate sensory and affective circuits.
  • Genetic silencing of these thalamic CGRP neurons preserved basic pain detection while abolishing learned fear and avoidance behaviors in mice.
  • Optogenetic activation of the same neurons triggered distress and conditioned avoidance even in the absence of painful stimuli, confirming their role in emotional suffering.
  • Transcriptomic profiling showed these CGRP-positive neurons express genes linked to migraine and other chronic pain conditions, suggesting a molecular basis for affective pain disorders.
  • Building on these results, the team is preparing human translational trials to evaluate whether existing CGRP blockers can specifically reduce the emotional burden of chronic pain and trauma-related disorders.